COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,798 Articles (22,527 medRxiv, 8,271 bioRxiv)

Most recent first Previous |  Page 161: Articles 1601-1610  | Next

Disruption of Immune Responses By Type I Diabetes Exacerbates SARS-CoV-2 Mediated Lung Injury
Kass Gergi, S., Zhao, G., Wong, J., Weiner, A. I., Adam Tzivelekidis, S., Gentile, M. E., Mendoza, M., Holcomb, N. P., Li, X., Singh, M., Vaughan, A. E.
10.1101/2024.05.31.596857 — Posted: 2024-05-31
Variable rates of SARS-CoV-2 evolution in chronic infections
Smith, E., Hamilton, W. L., Warne, B., Walker, E. R., Jahun, A. S., Hosmillo, M., ISARIC Consortium, , Gupta, R. K., Goodfellow, I., Gkrania-Klotsas, E., Torok, M. E., Illingworth, C. J. R.
10.1101/2024.05.31.596818 — Posted: 2024-05-31
Conceptual framework of episodic disability in the context of Long COVID: Findings from a community-engaged international qualitative study
O'Brien, K. K., Brown, D. A., McDuff, K., St. Clair-Sullivan, N., Chan Carusone, S., Thomson, C., McCorkell, L., Wei, H., Goulding, S., O'Hara, M., Roche, N., Stokes, R., Kelly, M., Cheung, A. M., Erlandson, K. M., Harding, R., Vera, J. H., Bergin, C., Avery, L., Robinson, L., Bannan, C., Torres, B., O'Donovan, I., Malli, N., Solomon, P.
10.1101/2024.05.28.24308048 — Posted: 2024-05-30
The Impact of Preprints on COVID-19 Research Dissemination: A Quantitative Analysis of Journal Publications
Tsunoda, H., Sun, Y., Nishizawa, M., Liu, X., Amano, K., Kominami, R.
10.1101/2024.05.28.596359 — Posted: 2024-05-29
SARS-CoV-2 correlates of protection from infection against variants of concern
Sun, K., Bhiman, J. N., Tempia, S., Kleynhans, J., Madzorera, V. S., Mkhize, Q., Kaldine, H., McMorrow, M. L., Wolter, N., Moyes, J., Carrim, M., Martinson, N. A., Kahn, K., Lebina, L., du Toit, J. D., Mkhencele, T., von Gottberg, A., Viboud, C., Moore, P. L., Cohen, C., PHIRST-C group
10.1101/2024.05.28.24308095 — Posted: 2024-05-29
Continuous quality improvement with a two-step strategy effective for large-scale SARS-CoV-2 screening at the Tokyo 2020 Olympic and Paralympic Games
Miyachi, H., Asai, S., Kuroki, R., Omi, K., Ikenoue, C., Shimada, S.
10.1101/2024.05.29.24307666 — Posted: 2024-05-29
Differential prevalence and risk factors for infection with coronaviruses in bats collected during 2020 in Yunnan Province, China
Li, R., Tendu, A., Kane, Y., Omondi, V., Ying, J., Mao, L., Xu, S., Xu, R., Chen, X., Chen, Y., Declere, S. D., Bienes, K. M., Fassatoui, M., Hughes, A. C., Berthet, N., Wong, G.
10.1101/2024.05.28.596354 — Posted: 2024-05-29
Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages
Wang, Q., Mellis, I. A., Bowen, A., Kowalski-Dobson, T., Valdez, R., Katsamba, P. S., Shapiro, L., Gordon, A., Guo, Y., Ho, D. D., Liu, L.
10.1101/2024.05.29.596362 — Posted: 2024-05-29
Impact of variants and vaccination on nasal immunity across three waves of SARS-CoV-2
Long, J. M., Miao, V. N., Owings, A. H., Tang, Y., Bromley, J. D., Kazer, S. W., Kimler, K., Asare, C., Ziegler, C. G. K., Ibrahim, S., Jivanjee, T., George, M., Navia, A. W., Drake, R. S., Parker, A., Billingsley, B. C., Dotherow, P., Tarugu, S., Kota, S. K., Laird, H., Wichman, T. G., Davis, Y. T., Dhaliwal, N. S., Pride, Y., Guo, Y., Senitko, M., Harvey, J., Bates, J. T., Diamond, G., Garrett, M. R., Robinson, D. A., Frame, I. J., Lyons, J. J., Robinson, T. O., Shalek, A. K., Horwitz, B. H., Glover, S. C., Ordovas-Montanes, J.
10.1101/2024.05.29.596308 — Posted: 2024-05-29
Dissecting the ocular impact of SARS-CoV-2 variants: Analysis of eye globe and retina in animal models
da Silva, J. I. G., Kersten, V., Munhoz Dati, L. M., Lins, B. B., Tozetto-Mendoza, T. R. A. P., Rodrigues, D. d. R. F., Barbosa, R. J. V., Lima, S. H., Villas Boas, L. S., da Silva, A. d. S., Chaim, K. T., Mendes-Correa, M. C., Russo, M., Mirotti, L., Pinto, M. A., Martins, R. A. P.
10.1101/2024.05.29.596469 — Posted: 2024-05-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).